Selma Blair Is ‘Grieving’ But ‘Still Grateful’ at First Thanksgiving Since Her MS Diagnosis

People Magazine reported today that five months after being diagnosed with multiple sclerosis, actress Selma Blair has “been grieving” her old life but is “still grateful”...

Using Statin’s in multiple sclerosis treatment

Scientists are hopeful a major drug trial will establish that statins can be used to treat multiple sclerosis.The low-cost drugs are typically prescribed to...

My MS and Me Story

MS and Me blogger Debra Gaston Brigman shares her most recent blog written last month.  It is a very personal account of her MS...

Surprise discovery may lead potential treatment for multiple sclerosis

Canada - A surprise finding by medical scientists may lead to the development of a possible treatment for multiple sclerosis (MS).While examining human brain...
video

How I kept faith after losing my baby boy – Living with Multiple Sclerosis

Life comes at you fast.I never expected to face some of life’s most challenging moments — all in the course of three years:Being diagnosed with...
video

Allen Bowling, MD, PhD, talks about multiple sclerosis, marijuana and other unconventional therapies

Allen Bowling, MD, PhD, talks about multiple sclerosis clinicians' limited training in unconventional therapy at the Consortium of Multiple Sclerosis Centers (CMSC) 2017.
video

Introducing the Barts MS Charity – “Lets Find Answers Together”

What is the objective of Barts MS Charity?To enable Barts-MS to undertake hard-to-fund, or to prime important, MS research projects.Our first key objective is to...
video

MS GOSS

Meet Grace Sanders our newest show host on MS and Me Radio.  Actress, singer, LIPA grad and self described “massively sassy” Grace shares her MS...

My MS Story: The Rules I’ve Made For Me Over The Years

I have been living with MS and a long list of autoimmune diseases for over 40 years.  I have been an educator, but I...

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS

SOURCE Novartis- Breakthrough Therapy designation can expedite the development and review of therapies for serious conditions- In a pivotal Phase III study, oral fingolimod...

Social Media

834FollowersFollow